-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Buy on Arrowhead Pharma, Raises Price Target to $62

Benzinga·12/01/2025 16:40:05
Listen to the news
B of A Securities analyst Jason Gerberry maintains Arrowhead Pharma (NASDAQ:ARWR) with a Buy and raises the price target from $42 to $62.